Amrize Ltd (AMRZ) is an innovative technology company at the forefront of the digital health and wellness sector, dedicated to transforming healthcare delivery through advanced technologies and data-driven solutions. With a strong focus on improving patient outcomes and enhancing accessibility, Amrize invests significantly in research and development to meet the growing demand for scalable health innovations. Its strategic initiatives and diverse product offerings position the company as a key player in modern healthcare transformation, presenting a compelling opportunity for institutional investors in a rapidly evolving market.
| Revenue (TTM) | $11.91B |
| Gross Profit (TTM) | $3.02B |
| EBITDA | $2.81B |
| Operating Margin | -3.54% |
| Return on Equity | 10.10% |
| Return on Assets | 4.95% |
| Revenue/Share (TTM) | $21.54 |
| Book Value | $23.66 |
| Price-to-Book | 2.11 |
| Price-to-Sales (TTM) | 2.32 |
| EV/Revenue | 2.809 |
| EV/EBITDA | 12.09 |
| Quarterly Earnings Growth (YoY) | 3.60% |
| Quarterly Revenue Growth (YoY) | 4.70% |
| Shares Outstanding | $553.54M |
| Float | $493.23M |
| % Insiders | 7.28% |
| % Institutions | 53.49% |
Volatility is currently contracting